These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31025282)

  • 1. Nanoinformatics and biomolecular nanomodeling: a novel move en route for effective cancer treatment.
    Sharma N; Sharma M; Sajid Jamal QM; Kamal MA; Akhtar S
    Environ Sci Pollut Res Int; 2020 Jun; 27(16):19127-19141. PubMed ID: 31025282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoinformatics and Personalized Medicine: An Advanced Cumulative Approach for Cancer Management.
    Khan F; Akhtar S; Kamal MA
    Curr Med Chem; 2023; 30(3):271-285. PubMed ID: 35692148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoinformatics Revolutionizes Personalized Cancer Therapy.
    Sadan T; Cormode DP; Popovtzer R
    Trends Cancer; 2018 Jun; 4(6):397-399. PubMed ID: 29860981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoinformatics for biomedicine: emerging approaches and applications.
    Liu X; Webster TJ
    Int J Nanomedicine; 2013; 8 Suppl 1(Suppl 1):1-5. PubMed ID: 24101873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoinformatics: emerging databases and available tools.
    Panneerselvam S; Choi S
    Int J Mol Sci; 2014 Apr; 15(5):7158-82. PubMed ID: 24776761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
    Hock SC; Ying YM; Wah CL
    PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoinformatics and DNA-based computing: catalyzing nanomedicine.
    Maojo V; Martin-Sanchez F; Kulikowski C; Rodriguez-Paton A; Fritts M
    Pediatr Res; 2010 May; 67(5):481-9. PubMed ID: 20118825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation.
    Luan X; Yuan H; Song Y; Hu H; Wen B; He M; Zhang H; Li Y; Li F; Shu P; Burnett JP; Truchan N; Palmisano M; Pai MP; Zhou S; Gao W; Sun D
    Biomaterials; 2021 Aug; 275():120910. PubMed ID: 34144373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International efforts in nanoinformatics research applied to nanomedicine.
    de la Iglesia D; Maojo V; Chiesa S; Martin-Sanchez F; Kern J; Potamias G; Crespo J; Garcia-Remesal M; Keuchkerian S; Kulikowski C; Mitchell JA
    Methods Inf Med; 2011; 50(1):84-95. PubMed ID: 21085742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoinformatics: developing new computing applications for nanomedicine.
    Maojo V; Fritts M; Martin-Sanchez F; De la Iglesia D; Cachau RE; Garcia-Remesal M; Crespo J; Mitchell JA; Anguita A; Baker N; Barreiro JM; Benitez SE; De la Calle G; Facelli JC; Ghazal P; Geissbuhler A; Gonzalez-Nilo F; Graf N; Grangeat P; Hermosilla I; Hussein R; Kern J; Koch S; Legre Y; Lopez-Alonso V; Lopez-Campos G; Milanesi L; Moustakis V; Munteanu C; Otero P; Pazos A; Perez-Rey D; Potamias G; Sanz F; Kulikowski C
    Comput Sci Eng; 2012 Jun; 94(6):521-539. PubMed ID: 22942787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merging data curation and machine learning to improve nanomedicines.
    Chen C; Yaari Z; Apfelbaum E; Grodzinski P; Shamay Y; Heller DA
    Adv Drug Deliv Rev; 2022 Apr; 183():114172. PubMed ID: 35189266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical and computational modeling of nano-engineered drug delivery systems.
    Shamsi M; Mohammadi A; Manshadi MKD; Sanati-Nezhad A
    J Control Release; 2019 Aug; 307():150-165. PubMed ID: 31229474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research.
    de la Iglesia D; Cachau RE; García-Remesal M; Maojo V
    Comput Sci Discov; 2013 Nov; 6(1):014011. PubMed ID: 24932210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine applied to translational oncology: A future perspective on cancer treatment.
    Bregoli L; Movia D; Gavigan-Imedio JD; Lysaght J; Reynolds J; Prina-Mello A
    Nanomedicine; 2016 Jan; 12(1):81-103. PubMed ID: 26370707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology: Revolutionizing the Science of Drug Delivery.
    Mishra M; Kumar P; Rajawat JS; Malik R; Sharma G; Modgil A
    Curr Pharm Des; 2018; 24(43):5086-5107. PubMed ID: 30727873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoinformatics: a new area of research in nanomedicine.
    Maojo V; Fritts M; de la Iglesia D; Cachau RE; Garcia-Remesal M; Mitchell JA; Kulikowski C
    Int J Nanomedicine; 2012; 7():3867-90. PubMed ID: 22866003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European efforts in nanoinformatics research applied to nanomedicine.
    Chiesa S; De La Iglesia D; Crespo J; Martin-Sanchez F; Kern J; Potamias G; Maojo V
    Stud Health Technol Inform; 2009; 150():757-61. PubMed ID: 19745412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Clinical Translation of Cancer Using Nanoinformatics.
    Soltani M; Moradi Kashkooli F; Souri M; Zare Harofte S; Harati T; Khadem A; Haeri Pour M; Raahemifar K
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
    Ozeki T; Tagami T
    Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.